Filings

Finds words inside filing documents. Searching 60 DEGREES PHARMACEUTICALS, INC.'s filings · 41 documents indexed.

6 documents · 19 matches

SXTP 60 DEGREES PHARMACEUTICALS, INC. 10-Q 2026-08-14

Item 4. Controls and Procedures. Disclosure Controls and Procedures
June 30, 2026, due to the existence of material weaknesses in our internal control over financial reporting. These material weaknesses are described below:
5 matches in this document
SXTP 60 DEGREES PHARMACEUTICALS, INC. 10-Q 2026-05-15

Item 4. Controls and Procedures. Disclosure Controls and Procedures
March 31, 2026, due to the existence of material weaknesses in our internal control over financial reporting. These material weaknesses are described below:
2 matches in this document
SXTP 60 DEGREES PHARMACEUTICALS, INC. 10-K 2026-03-30

Item 9A. Controls and Procedures.
December 31, 2025, due to the existence of material weaknesses in our internal control over financial reporting. These material weaknesses are described below:
3 matches in this document
SXTP 60 DEGREES PHARMACEUTICALS, INC. 10-Q 2025-11-13

Item 4. Controls and Procedures. Disclosure Controls and Procedures
material weakness in the Company’s internal control over financial reporting described below, the Company’s disclosure controls and procedures
3 matches in this document
SXTP 60 DEGREES PHARMACEUTICALS, INC. 10-Q 2025-08-13

Item 4. Controls and Procedures. Disclosure Controls and Procedures
material weakness in the Company’s internal control over financial reporting described below, the Company’s disclosure controls and procedures
3 matches in this document
SXTP 60 DEGREES PHARMACEUTICALS, INC. 10-Q 2025-05-15

Item 4. Controls and Procedures. Disclosure Controls and Procedures
material weakness in the Company’s internal control over financial reporting described below, the Company’s disclosure controls and procedures
3 matches in this document

Page 1 of 1 · 6 documents